Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the medtronic model dtma2d4 claria mri dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (crt-d) is a multiprogrammable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies. medtronic claria mri model dtma2d4 cardiac resynchronization therapy implantable defibrillators (crt-ds) are indicated for use in patients who are at significant risk of developing life-threatening ventricular tachyarrhythmias and who have heart failure with ventricular arrhythmias. heart failure patients must have experienced one or more of the following conditions: ? ventricular dyssynchrony with prolonged qrs ? reduced ejection fraction (ef), regardless of new york heart association (nyha) class, if the patient is indicated for ventricular pacing and has high degree atrioventricular (av) block ? reduced ef with all of the following characteristics: ? the patient received a conventional pacemaker or an implantable cardioverter defibrillator (icd). ? the patient subsequently developed worsening heart failure despite optimal medical therapy. ? the patient has a high proportion of right ventricular (rv) pacing.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the medtronic model dtma2q1 claria mri quad dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (crt-d) is a multiprogrammable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies medtronic claria mri quad model dtma2q1 cardiac resynchronization therapy implantable defibrillators (crt-ds) are indicated for use in patients who are at significant risk of developing life-threatening ventricular tachyarrhythmias and who have heart failure with ventricular arrhythmias. heart failure patients must have experienced one or more of the following conditions: ? ventricular dyssynchrony with prolonged qrs ? reduced ejection fraction (ef), regardless of new york heart association (nyha) class, if the patient is indicated for ventricular pacing and has high degree atrioventricular (av) block ? reduced ef with all of the following characteristics: ? the patient received a conventional pacemaker or an implantable cardioverter defibrillator (icd). ? the patient subsequently developed worsening heart failure despite optimal medical therapy. ? the patient has a high proportion of right ventricular (rv) pacing.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the medtronic model dtma2qq claria mri quad dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (crt-d) is a multiprogrammable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies. medtronic claria mri quad model dtma2qq cardiac resynchronization therapy implantable defibrillators (crt-ds) are indicated for use in patients who are at significant risk of developing life-threatening ventricular tachyarrhythmias and who have heart failure with ventricular arrhythmias. heart failure patients must have experienced one or more of the following conditions: ? ventricular dyssynchrony with prolonged qrs ? reduced ejection fraction (ef), regardless of new york heart association (nyha) class, if the patient is indicated for ventricular pacing and has high degree atrioventricular (av) block ? reduced ef with all of the following characteristics: ? the patient received a conventional pacemaker or an implantable cardioverter defibrillator (icd). ? the patient subsequently developed worsening heart failure despite optimal medical therapy. ? the patient has a high proportion of right ventricular (rv) pacing.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the devices in this application are dual chamber, implantable cardioverter defibrillators with cardiac resynchronization therapy (crt-d). these multiprogrammable cardiac devices monitor and regulate the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies. the devices feature bluetooth wireless technology. lead connector: is-1/df-1 the medtronic cobalt hf crt-d mri surescan model dtpb2d1 implantable cardiac resynchronization therapy defibrillator is indicated for use in patients who are at significant risk of developing life-threatening ventricular tachyarrhythmias and who have heart failure with ventricular arrhythmias. heart failure patients must have experienced one or more of the following conditions: ? ventricular dyssynchrony with prolonged qrs ? reduced ejection fraction (ef), regardless of new york heart association (nyha) class, if the patient is indicated for ventricular pacing and has high degree atrioventricular (av) block ? reduced ef with all the following characteristics: ? the patient received a conventional pacemaker or an implantable cardioverter defibrillator (icd). ? the patient subsequently developed worsening heart failure despite optimal medical therapy. ? the patient has a high proportion of right ventricular (rv) pacing

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the model dtpb2q1 dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (crt-d) is a multiprogrammable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies. this device features bluetooth wireless technology. lead connector type: is4/df-1 the medtronic cobalt hf quad crt-d mri surescan model dtpb2q1 implantable cardiac resynchronization therapy defibrillator is indicated for use in patients who are at significant risk of developing life-threatening ventricular tachyarrhythmias and who have heart failure with ventricular arrhythmias. heart failure patients must have experienced one or more of the following conditions: ? ventricular dyssynchrony with prolonged qrs ? reduced ejection fraction (ef), regardless of new york heart association (nyha) class, if the patient is indicated for ventricular pacing and has high degree atrioventricular (av) block ? reduced ef with all the following characteristics: ? the patient received a conventional pacemaker or an implantable cardioverter defibrillator (icd). ? the patient subsequently developed worsening heart failure despite optimal medical therapy. ? the patient has a high proportion of right ventricular (rv) pacing

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the model dtpa2d4 dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (crt-d) is a multiprogrammable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies. this device features bluetooth wireless technology. lead connector type: is-1/df-4 the medtronic cobalt xt hf crt-d mri surescan model dtpa2d4 implantable cardiac resynchronization therapy defibrillator is indicated for use in patients who are at significant risk of developing life-threatening ventricular tachyarrhythmias and who have heart failure with ventricular arrhythmias. heart failure patients must have experienced one or more of the following conditions: ? ventricular dyssynchrony with prolonged qrs ? reduced ejection fraction (ef), regardless of new york heart association (nyha) class, if the patient is indicated for ventricular pacing and has high degree atrioventricular (av) block ? reduced ef with all the following characteristics: ? the patient received a conventional pacemaker or an implantable cardioverter defibrillator (icd). ? the patient subsequently developed worsening heart failure despite optimal medical therapy. ? the patient has a high proportion of right ventricular (rv) pacing

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the model dtpa2q1 dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (crt-d) is a multiprogrammable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies. this device features bluetooth wireless technology. lead connector: is4/df-1 the medtronic cobalt xt hf quad crt-d mri surescan model dtpa2q1 implantable cardiac resynchronization therapy defibrillator is indicated for use in patients who are at significant risk of developing life-threatening ventricular tachyarrhythmias and who have heart failure with ventricular arrhythmias. heart failure patients must have experienced one or more of the following conditions: ? ventricular dyssynchrony with prolonged qrs ? reduced ejection fraction (ef), regardless of new york heart association (nyha) class, if the patient is indicated for ventricular pacing and has high degree atrioventricular (av) block ? reduced ef with all the following characteristics: ? the patient received a conventional pacemaker or an implantable cardioverter defibrillator (icd). ? the patient subsequently developed worsening heart failure despite optimal medical therapy. ? the patient has a high proportion of right ventricular (rv) pacing

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the devices in this application are dual chamber, implantable cardioverter defibrillators with cardiac resynchronization therapy (crt-d). these multiprogrammable cardiac devices monitor and regulate the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies. the devices feature bluetooth wireless technology. lead connector: is-1/df-1 the medtronic crome hf crt-d mri surescan model dtpc2d1 implantable cardiac resynchronization therapy defibrillator is indicated for use in patients who are at significant risk of developing life-threatening ventricular tachyarrhythmias and who have heart failure with ventricular arrhythmias. heart failure patients must have experienced one or more of the following conditions: ? ventricular dyssynchrony with prolonged qrs ? reduced ejection fraction (ef), regardless of new york heart association (nyha) class, if the patient is indicated for ventricular pacing and has high degree atrioventricular (av) block ? reduced ef with all the following characteristics: ? the patient received a conventional pacemaker or an implantable cardioverter defibrillator (icd). ? the patient subsequently developed worsening heart failure despite optimal medical therapy. ? the patient has a high proportion of right ventricular (rv) pacing

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the model dtpc2q1 dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (crt-d) is a multiprogrammable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies. this device features bluetooth wireless technology. is4/df-1 the medtronic crome hf quad crt-d mri surescan model dtpc2q1 implantable cardiac resynchronization therapy defibrillator is indicated for use in patients who are at significant risk of developing life-threatening ventricular tachyarrhythmias and who have heart failure with ventricular arrhythmias. heart failure patients must have experienced one or more of the following conditions: ? ventricular dyssynchrony with prolonged qrs ? reduced ejection fraction (ef), regardless of new york heart association (nyha) class, if the patient is indicated for ventricular pacing and has high degree atrioventricular (av) block ? reduced ef with all the following characteristics: ? the patient received a conventional pacemaker or an implantable cardioverter defibrillator (icd). ? the patient subsequently developed worsening heart failure despite optimal medical therapy. ? the patient has a high proportion of right ventricular (rv) pacing

Australia - English - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 47270 - biventricular pacemaker/defibrillator - the model dtpb2d4 dual chamber, implantable cardioverter defibrillator with cardiac resynchronization therapy (crt-d) is a multiprogrammable cardiac device that monitors and regulates the patient?s heart rate by providing single or dual chamber, rate-responsive bradycardia pacing; sequential biventricular pacing; ventricular tachyarrhythmia therapies; and atrial tachyarrhythmia therapies. this device features bluetooth wireless technology. lead connector type: is-1/df-4 the medtronic cobalt hf crt-d mri surescan model dtpb2d4 implantable cardiac resynchronization therapy defibrillator is indicated for use in patients who are at significant risk of developing life-threatening ventricular tachyarrhythmias and who have heart failure with ventricular arrhythmias. heart failure patients must have experienced one or more of the following conditions: ? ventricular dyssynchrony with prolonged qrs ? reduced ejection fraction (ef), regardless of new york heart association (nyha) class, if the patient is indicated for ventricular pacing and has high degree atrioventricular (av) block ? reduced ef with all the following characteristics: ? the patient received a conventional pacemaker or an implantable cardioverter defibrillator (icd). ? the patient subsequently developed worsening heart failure despite optimal medical therapy. ? the patient has a high proportion of right ventricular (rv) pacing